About 7 results found for searched term "Ac2-26" (0.06 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M4925 | Enoxacin hydrate | Antibiotic |
| Enoxacin sesquihydrate; AT-2266 hydrate; CI-919 hydrate | ||
| Enoxacin is a broad-spectrum 6-fluoronaphthyridinone antibacterial agent. | ||
| M9161 | NVP-ACC789 | VEGFR/PDGFR |
| ACC-789; ZK-202650 | ||
| NVP-ACC789 is an inhibitor of human VEGFR-1, VEGFR-2 (mouse VEGFR-2), VEGFR-3 and PDGFR-β with IC50s of 0.38, 0.02 (0.23), 0.18, 1.4 μM, respectively. | ||
| M13449 | Ac2-26 TFA | NF-κB |
| Ac2-26 TFA, an active N-terminal peptide of adiponectin A1 (AnxA1), alleviates acute lung injury induced by ischemia-reperfusion. Ac2-26 also decreased AnxA1 protein expression and inhibited the activation of NF-κB and MAPK pathways in damaged lung tissue. Sequence Shortening: Ala-Met-Val-Ser-Glu-Phe-Leu-Lys-GIn-Ala-Trp-Phe-lle-Glu-Asn-Glu-Glu-GIn-Glu-Tyr-Val-GIn-Thr-Val-Lys | ||
| M14716 | Ibiglustat (L-Malic acid) | Glucosylceramide Synthase |
| Venglustat (L-Malic acid); SAR402671 (L-Malic acid); GZ402671 (L-Malic acid) | ||
| Ibiglustat (Venglustat) L-Malic acid is an orally active, brain-penetrant glucosylceramide synthase (GCS) inhibitor. | ||
| M44503 | 12beta-Acetoxy-3beta-hydroxy-7,11,15,23-tetraoxo-lanost-8,20-diene-26-oic acid | Others |
| 12beta-Acetoxy-3beta-hydroxy-7,11,15,23-tetraoxo-lanost-8,20-diene-26-oic acid | ||
| M44538 | 12beta-Acetoxy-3,7,11,15,23-pentaoxo-lanost-8,20-dien-26-oic acid | Others |
| 12beta-Acetoxy-3,7,11,15,23-pentaoxo-lanost-8,20-dien-26-oic acid | ||
| M54279 | Ac2-26 | NF-κB |
| Ac2-26, an active N-terminal peptide of annexin A1 (AnxA1), attenuates ischemia-reperfusion-induced acute lung injury. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.
